Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

My hands shook as I texted my husband. I felt unmoored in my body, as if I’d awoken in a different house than the one where I ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

A New Target for Treatment of One Type of Macular Degeneration ... June 7, 2024 — New eye-tracking research has shown that simply looking at natural elements during urban walks can offer ...

Multiple artists we spoke to unanimously agreed that the brand Viseart makes some of the best eye-shadow palettes on the ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...